NeuroPace (NPCE) Cash & Equivalents (2020 - 2026)
NeuroPace (NPCE) posted quarterly Cash & Equivalents of $14.8 million for Q1 2026, down 45.3% year-over-year from $27.0 million in Q1 2025, and down 31.87% quarter-over-quarter from $21.7 million in Q4 2025.
NeuroPace (NPCE) Cash & Equivalents (2020 - 2026) Analysis & Trends
NeuroPace's Cash & Equivalents history runs 7 years deep, the most recent figure standing at $14.8 million for Q1 2026.
- In Q1 2026, Cash & Equivalents fell 45.3% year-over-year to $14.8 million; the TTM figure through Mar 2026 stood at $14.8 million (down 45.3% YoY), while the FY2025 annual figure was $21.7 million, up 61.52% from the prior year.
- Cash & Equivalents for Q1 2026 stood at $14.8 million, down from $21.7 million in the prior quarter.
- The five-year high for Cash & Equivalents was $27.0 million in Q1 2025, with the low at $5.7 million in Q3 2022.
- The 5-year median for Cash & Equivalents is $13.0 million (2024), against an average of $13.5 million.
- The sharpest annual moves came in 2022 and 2023: Cash & Equivalents slumped 81.75% in 2022, then jumped 173.4% in 2023.
- NeuroPace's Cash & Equivalents stood at $6.6 million in 2022, then surged by 173.4% to $18.1 million in 2023, then fell by 25.63% to $13.4 million in 2024, then surged by 61.52% to $21.7 million in 2025, then sank by 31.87% to $14.8 million in 2026.
- Business Quant data shows NPCE's Cash & Equivalents at $14.8 million in Q1 2026, $21.7 million in Q4 2025, and $20.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.46 Bn | 193.86 Bn | 7.27 Bn | 5.10 Bn |
| 2 | Stryker | 127.41 Bn | 123.93 Bn | 4.50 Bn | 3.39 Bn |
| 3 | Medtronic | 118.87 Bn | 109.65 Bn | 6.41 Bn | 1.95 Bn |
| 4 | Boston Scientific | 73.47 Bn | 72.93 Bn | 3.85 Bn | 539.00 Mn |
| 5 | Edwards Lifesciences | 51.95 Bn | 47.69 Bn | 1.35 Bn | 2.91 Bn |
| 6 | Dexcom | 34.30 Bn | 32.35 Bn | 830.00 Mn | 1.11 Bn |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn | 2.11 Bn |
| 8 | Koninklijke Philips | 26.35 Bn | 23.02 Bn | 4.55 Bn | 3.25 Bn |
| 9 | Steris | 23.04 Bn | 22.55 Bn | 684.20 Mn | 482.30 Mn |
| 10 | NeuroPace | 463.82 Mn | 412.12 Mn | 18.91 Mn | 12.54 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 12.54 Mn |
| Mar 31, 2026 | 14.78 Mn |
| Dec 31, 2025 | 21.69 Mn |
| Sep 30, 2025 | 20.65 Mn |
| Jun 30, 2025 | 22.86 Mn |
| Mar 31, 2025 | 27.02 Mn |
| Dec 31, 2024 | 13.43 Mn |
| Sep 30, 2024 | 15.42 Mn |
| Jun 30, 2024 | 12.84 Mn |
| Mar 31, 2024 | 13.00 Mn |
| Dec 31, 2023 | 18.06 Mn |
| Sep 30, 2023 | 9.72 Mn |
| Jun 30, 2023 | 7.86 Mn |
| Mar 31, 2023 | 6.72 Mn |
| Dec 31, 2022 | 6.61 Mn |
| Sep 30, 2022 | 5.69 Mn |
| Jun 30, 2022 | 5.70 Mn |
| Mar 31, 2022 | 7.49 Mn |
| Dec 31, 2021 | 19.19 Mn |
| Sep 30, 2021 | 26.63 Mn |